Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
Posted On: 12/17/2015 9:22:27 PM
Post# of 72445
Avatar
Posted By: Drano
Re: biodoc #16713
Ulcerative proctitis affects a smaller, more easily accessible area so it seems very smart to use that for proof of concept. I assume that proctoscopy would be needed during the course of the trial to gauge safety and (hopefully) efficacy. People are going to have to be pretty motivated to be in a clinical trial for this application if that kind of evidence is needed, rather than just patients' reports of their symptoms or alleviation of symptoms. Biodoc, what do you think -- is anecdotal evidence enough, or would the study be likely to require several procedures? Is it possible that they could have a subset of patients who have the procedures, and use anecdotal reports for most of the patients?













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site